Literature DB >> 8773776

Impairment of protein kinase C activity in twitcher Schwann cells in vitro.

H Yamada1, P Martin, K Suzuki.   

Abstract

Twitcher (twi/twi) is a murine model of globoid cell leukodystrophy in humans caused by a genetic deficiency in activity of galactosylceramidase. Our previous study demonstrated that the rate of Schwann cell proliferation in twi/twi was considerably lower than that of the control (+/+) in vitro. We hypothesize that the lower mitotic rate in twi/twi results from the metabolic perturbation of Schawann cells caused by an accumulation of the toxic metabolite of galactosylceramidase, psychosine, a potent inhibitor of protein kinase C (PKC). Mouse Schwann cells are known to be stimulated to divide by growth factors in media containing fetal bovine serum. The stimulation by glial growth factor (GGF) or platelet-derived growth factor-BB (PDGF-BB) is though to be through the PKC pathway, but not by the basic fibroblast growth factor (bFGF) or transforming growth factor-beta (TGF-beta). Thus, we tested responses of twi/twi and +/+ Schwann cells to these growth factors. Schwann cells were isolated from the dorsal root ganglia at 30 days of age and the experiments were carried out at 21 days in vitro. In media containing PDGF-BB or bovine pituitary extract (BPE), the mitotic rate of twi/twi Schwann cells was 76% or 69% of the +/+ value, respectively, while significant differences were detected between twi/twi and +/+ in cultures containing TGF-beta or bFGF. When phorbol 12,13-dibutyrylate, a specific activator of PKC, was added to the media containing PDGF-BB or BPE, the mitotic rate of twi/twi Schwann cells improved up to 90% of +/+ cells. Staurosporine, an inhibitor of PKC. suppressed the proliferation of both twi/twi and +/+ Schwann cells. However, proliferation of twi/twi Schwann cells was suppressed by one-tenth of the concentration required for +/+ Schwann cells. These results are consistent with an accumulation of psychosine, an inhibitor of PKC, and suggest that the signal transduction system through PKC is impaired in the twi/twi Schwann cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773776     DOI: 10.1016/0006-8993(96)00098-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Pathology and current treatment of neurodegenerative sphingolipidoses.

Authors:  Matthias Eckhardt
Journal:  Neuromolecular Med       Date:  2010-08-22       Impact factor: 3.843

2.  Molecular beacon genotyping for globoid cell leukodystrophy from hair roots in the twitcher mouse and rhesus macaque.

Authors:  Kimberly A Terrell; Terri A Rasmussen; Cyndi Trygg; Bruce A Bunnell; Wayne R Buck
Journal:  J Neurosci Methods       Date:  2007-02-25       Impact factor: 2.390

Review 3.  Peripheral neuropathy in the Twitcher mouse involves the activation of axonal caspase 3.

Authors:  Benjamin Smith; Francesca Galbiati; Ludovico Cantuti Castelvetri; Maria I Givogri; Aurora Lopez-Rosas; Ernesto R Bongarzone
Journal:  ASN Neuro       Date:  2011       Impact factor: 4.146

4.  Inhibition of cytokinesis by a lipid metabolite, psychosine.

Authors:  T Kanazawa; S Nakamura; M Momoi; T Yamaji; H Takematsu; H Yano; H Sabe; A Yamamoto; T Kawasaki; Y Kozutsumi
Journal:  J Cell Biol       Date:  2000-05-15       Impact factor: 10.539

5.  Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity.

Authors:  Christopher J Folts; Nicole Scott-Hewitt; Christoph Pröschel; Margot Mayer-Pröschel; Mark Noble
Journal:  PLoS Biol       Date:  2016-12-15       Impact factor: 8.029

6.  Inhibition of the IGF-1-PI3K-Akt-mTORC2 pathway in lipid rafts increases neuronal vulnerability in a genetic lysosomal glycosphingolipidosis.

Authors:  Tuba Sural-Fehr; Harinder Singh; Ludovico Cantuti-Catelvetri; Hongling Zhu; Michael S Marshall; Rima Rebiai; Martin J Jastrzebski; Maria I Givogri; Mark M Rasenick; Ernesto R Bongarzone
Journal:  Dis Model Mech       Date:  2019-05-23       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.